Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Wave Life Sci Ord Sh (NQ: WVE ) 6.020 +0.450 (+8.08%) Streaming Delayed Price Updated: 3:14 PM EDT, Jul 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Wave Life Sci Ord Sh < Previous 1 2 Next > Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia May 23, 2023 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting May 16, 2023 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update May 03, 2023 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023 April 26, 2023 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform Chemistry April 20, 2023 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days March 29, 2023 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update March 22, 2023 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 March 02, 2023 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference February 09, 2023 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Provides Positive Update on Proof-of-Concept Study for WVE-N531 in Duchenne Muscular Dystrophy December 19, 2022 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets December 13, 2022 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update November 10, 2022 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences to Present at the Stifel 2022 Healthcare Conference November 09, 2022 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences to Webcast Conference Call of Third Quarter 2022 Financial Results on November 10, 2022 November 03, 2022 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences to Highlight Advancements from PRISM Platform at Upcoming Scientific Congresses October 03, 2022 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Highlights Therapeutic Potential for WVE-006 for Alpha-1 Antitrypsin Deficiency and Progress Bringing RNA Editing to the Clinic During Analyst and Investor Event September 28, 2022 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences to Webcast Conference Call of Second Quarter 2022 Financial Results on August 11, 2022 July 28, 2022 From Wave Life Sciences USA, Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.